Phase Genomics

27 employees

Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Metagenomics

Genome assembly

Research

Customer satisfaction

Scientific discovery

Antibiotic Resistance

DNA Sequencing

Proximo

Scientific Research

genome

Microbiome

DNA

NGS

Genetics

Genomics

Structural Variation

Proximeta

Cancer

Biotech

Chromatin

Hi-C

science news

Plasmids

Human Genome

Bioinformatics

science

Diagnostic

Hi-C Kit

Date founded

2015

Funding rounds raised

Total raised

$5.5M

from 12 investors over 12 rounds

Phase Genomics raised $5.5M on June 9, 2022

Investors: National Institute of Allergy and Infectious Diseases (NIAID) and Bill & Melinda Gates Foundation

Phase Genomics raised $1.7M on February 23, 2021

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

Phase Genomics raised $3.9M on September 29, 2020

Investors: National Institutes of Health

Phase Genomics raised undisclosed on February 26, 2020

Investors: Hemi Ventures

Phase Genomics raised $1.5M on January 8, 2020

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

Phase Genomics raised $200K on February 25, 2019

Investors: Bill & Melinda Gates Foundation

Phase Genomics raised undisclosed on January 1, 2019

Investors: Sahsen Ventures, LLC

Phase Genomics raised $1.5M on June 27, 2018

Investors: National Institutes of Health

Phase Genomics raised $1M on December 3, 2017

Investors: Washington Research Foundation, FourCities Capital and Congruent Ventures